Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Psoriasis Clinical Research Samples
Discovery Life Sciences provides the highest quality Psoriasis Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Psoriasis Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 8 of 8 total samples
Buy | Product ID | Sample | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Test 2 | Test Data 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Blood Type | Current Medications | Diagnosis | Symptoms | ICD10 codes | Comprehensive Metabolic Panel | Complete Blood Count | Additional Testing | Lipid Panel Results | Environmental Factors |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EDP0000-AA900032755031518DD | Psoriasis | K2 EDTA Plasma | 1.00 | 5.00 | $75.00 | 56 Y | Female | Non-Hispanic | <-70C | 15-Mar-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | MRI - Some signs of Pneumofibrosis | Ultrasound - Chronic cholecystopancreatitis 13-Mar-2018 | Current Disease Status | Responding | $75.00 | Unknown | Nimesulide 100 mg/twice per day + Methylprednisolone 8 mg/day + Omeprazole 20 mg/day since 6-Feb-2018 | Psoriasis | Pain in cervical spine; Some zones of psoriatic rash (elbows and knees) 15-Mar-18 | L40.5 | Glucose 5.18 mmol/L | Creatinine 0.078 mmol/L | Sodium 142.4 mmol/L | Potassium 4.8 mmol/L | Total Protein 63 g/L | Albumin 50 g/L | Total Bilirubin 17.6 umol/L | SGOT (AST) 17 IU/L | SGPT (ALT) 24 IU/L | 14-Mar-2018 | WBC 7.7 x 10^9/L | RBC 4.4 x 10^12/L | Hemoglobin 122 g/L | Hematocrit 34.9% | MCV 78.1 fL | MCH 27.3 pg | MCHC 350 pg | Neutrophils 51% | Lymphocytes 42% | Monocytes 5% | Eosinophils 1% | 14-Mar-2018 | ANA - Negative | ESR - 50 mm/hour | RF - Negative | 14-Mar-2018 | Cholesterol 6.05 mmol/L | Triglycerides 2.14 mmol/L | 14-Mar-2018 | Previous Smoker 5-10 cigs per day for over 15 years | |||
| EDP0000-AA900032767042418DD | Psoriasis | K2 EDTA Plasma | 1.00 | 9.00 | $75.00 | 34 Y | Female | Non-Hispanic | <-70C | 24-Apr-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - Without pathology | X-ray - Normal 20-Apr-2018 | Current Disease Status | Stable | $75.00 | Unknown | Betamethasone-Salicylic acid ointment + Prednisolone 5 mg/day + Omeprazole 20 mg/day | Psoriasis | Positive clinical response 24-Apr-18 | L40.0 | Glucose 4.9 mmol/L | Creatinine 83 mmol/L | Sodium 139 mmol/L | Potassium 4.1 mmol/L | Total Protein 67.5 g/L | Total Bilirubin 8.3 umol/L | SGOT (AST) 28.2 IU/L | SGPT (ALT) 15.4 IU/L | 23-Apr-2018 | WBC 8.2 x 10^9/L | RBC 4.7 x 10^12/L | Hemoglobin 148 g/L | Hematocrit 43.3% | MCV 91.9 fL | MCH 31.2 pg | MCHC 341 g/L | Neutrophils 63% | Lymphocytes 26% | Monocytes 8% | Eosinophils 1% | Basophils 1% | 23-Apr-2018 | CRP 1.4 mg/L | 23-Apr-2018 | Cholesterol 5.2 mmol/L | 23-Apr-2018 | Current smoker 10-15 cigs per day for over 15 years | |||
| EDP0000-AA900061627032318DD | Psoriasis | K2 EDTA Plasma | 1.00 | 10.00 | $75.00 | 28 Y | Female | Non-Hispanic | <-70C | 23-Mar-18 | Clinical Diagnosis | Arthropathic Psoriasis | CT | MRI | Ultrasound | Xray Results | CT - Normal 15-Jan-2018 | Ultrasound - Urolithiasis 22-Mar-2018 | X-ray - Signs of osteoporosis, Marginal defects of bone tissue 22-Mar-2018 | Current Disease Status | Progressing | $75.00 | Unknown | Methotrexate 20 mg/day + Folic acid 10 mg/day + Calcium and Vitamin D (1000 mg/400 iu per day + Omeprazole 20 mg/day | Psoriasis | Psoriatic rash; Pain and swelling of small joints of hands and feet; Limitation of movements in cervical and thoracic spine 23-Mar-18 | L40.5 | Glucose 5.9 mmol/L | BUN 6.3 mmol/L | Creatinine 0.068 mmol/L | EGFR: 107 mL/min/1.73 m^2 | Sodium 141 mmol/L | Potassium 3.9 mmol/L | Total Bilirubin 5.0 umol/L | SGOT (AST) 4.8 IU/L | SGPT (ALT) 17 IU/L | 22-Mar-2018 | WBC 5.4 x 10^9/L | RBC 4.3 x 10^12/L | Hemoglobin 127 g/L | Hematocrit 35% | MCV 36.4 fL | MCH 31.5 pg | MCHC 364 g/L | Neutrophils 54% | Lymphocytes 38% | Monocytes 4% | Eosinophils 3% | Basophils 1% | 22-Mar-2018 | ANA - Negative | CRP 15 mg/L | RF 6.8 iu/mL | Iron 5.6 umol/L | Vitamin B12 279 ng/mL | Ferritin 8.12 ng/mL | 22-Mar-2018 | Cholesterol 5.6 mmol/L | 22-Mar-2018 | Diet; Current smoker 5-10 cigs per day | |||
| EDP0000-AA900069258040618DD | Psoriasis | K2 EDTA Plasma | 1.00 | 4.00 | $75.00 | 46 Y | Male | Non-Hispanic | <-70C | 06-Apr-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | CT - Pneumofibrosis 26-Dec-2017 | Ultrasound - Signs of chronic cholecystitis 5-Apr-2018 | X-ray - Sacroileitis Stage I-II 26-Dec-2017 | Current Disease Status | Flare | $75.00 | Unknown | Since 25-Jan-2018 Methotrexate 20 mg/day + Folic acid 5 mg/day + Diclofenac 200 mg/day + Methylprednisolone 4 mg/day + Omeprazole 20 mg/day + Pancreatin 30000 iu/day | Psoriasis | General fatigue, Psoriatic rash in zones of gluteal cleft, elbows and ears 6-Apr-18 | L40.5 | Glucose 6.5 mmol/L | Creatinine 105 mmol/L | Sodium 140.8 mmol/L | Potassium 5.1 mmol/L | Total Protein 74.2 g/L | SGOT (AST) 14.8 IU/L | SGPT (ALT) 16.3 IU/L | 5-Apr-2018 | WBC 7.4 x 10^9/L | RBC 4.9 x 10^12/L | Hemoglobin 140 g/L | Hematocrit 39% | MCH 28.4 pg | MCHC 349 g/L | Neutrophils 62% | Lymphocytes 32% | Monocytes 5% | Eosinophils 1% | | 5-Apr-2018 | ESR - 90 mm/hour | RF - Negative | Vitamin D - 15.5 ng/L | 5-Apr-2018 | Cholesterol 5.12 mmol/L | Triglycerides 2.6 mmol/L | HDL Cholesterol 1.7 mmol/L | Calculated LDL Cholesterol 3.0 mmol/L | 5-Apr-2018 | Diet; Previous smoker 15-20 cigs per day for 17-18 years | |||
| EDP0000-AA900081539031418DD | Psoriasis | K2 EDTA Plasma | 1.00 | 9.00 | $75.00 | 29 Y | Female | Non-Hispanic | <-70C | 14-Mar-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - Biliary dyskinesia | X-ray - Normal 13-Mar-2018 | Current Disease Status | Responding | $75.00 | Unknown | Prednisolone 2.5 mg/day + Omeprazole 20 mg/day since 13-Mar-2018 | Psoriasis | Psoriatic rash on scalp, elbows and ears (positive effect of treatment) 14-Mar-18 | L40.0 | Glucose 3.9 mmol/L | BUN 4.2 mmol/L | Creatinine 0.088 mmol/L | Sodium 142 mmol/L | Potassium 4.8 mmol/L | Total Protein 60.7 g/L | Total Bilirubin 11.6 umol/L | SGOT (AST) 15.9 IU/L | SGPT (ALT) 17.2 IU/L | 13-Mar-2018 | WBC 5.3 x 10^9/L | RBC 4.2 x 10^12/L | Hemoglobin 106 g/L | Hematocrit 34.8% | MCV 81.1 fL | MCH 25 pg | MCHC 308 g/L | Neutrophils 57.3% | Lymphocytes 32.8% | Monocytes 8.9% | Eosinophils 0.2% | Basophils 0.7% | 13-Mar-2018 | CRP 2.4 mg/L | 13-Mar-2018 | Cholesterol 5.1 mmol/L | 13-Mar-2018 | Current smoker 5-7 cigs per day for over 10 years | |||
| EDP0000-AA900081549042018DD | Psoriasis | K2 EDTA Plasma | 1.00 | 9.00 | $75.00 | 31 Y | Female | Non-Hispanic | <-70C | 20-Apr-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - without significant changes | X-ray - Normal 19-Apr-2018 | Current Disease Status | Newly diagnosed | $75.00 | Unknown | Betamethasone-Salicylic acid ointment + Loratadine 10 mg/day + Famotidine 20 mg/day | Psoriasis | Psoriatic rash on ears, umbilicus and genitalia 20-Apr-18 | L40.0 | Glucose 4.8 mmol/L | BUN 5.6 mmol/L | Creatinine 0.082 mmol/L | Sodium 141 mmol/L | Potassium 4.8 mmol/L | SGOT (AST) 29.4 IU/L | SGPT (ALT) 16.2 IU/L | 19-Apr-2018 | WBC 6.5 x 10^9/L | RBC 4.4 x 10^12/L | Hemoglobin 136 g/L | Hematocrit 40.8% | MCV 92.6 fL | MCH 30.4 pg | MCHC 329 g/L | Neutrophils 40.1% | Lymphocytes 35.4% | Monocytes 8.7% | Eosinophils 11.2% | Basophils 4.5% | 19-Apr-2018 | ANA - Negative | CRP 2.9 mg/L | 19-Apr-2018 | Not done | Current smoker 5-10 cigs per day for over 10 years | |||
| EDP0000-AA900081551032218DD | Psoriasis | K2 EDTA Plasma | 1.00 | 8.00 | $75.00 | 46 Y | Female | Non-Hispanic | <-70C | 22-Mar-18 | Clinical Diagnosis | Psoriatis Vulgaris | CT | MRI | Ultrasound | Xray Results | Ultrasound - No significant pathological data | X-ray - Normal 20-Mar-2018 | Current Disease Status | Newly diagnosed | $75.00 | Unknown | Betamethasone-Salicylic acid ointment + Loratadine 10 mg/day since 20-Mar-2018 | Psoriasis | Disseminated psoriatic rash 22-Mar-18 | L40.0 | Glucose 4.5 mmol/L | BUN 5.5 mmol/L | Creatinine 0.068 mmol/L | Total Bilirubin 10.8 umol/L | 20-Mar-2018 | WBC 7.2 x 10^9/L | RBC 4.15 x 10^12/L | Hemoglobin 120 g/L | Neutrophils 60.3% | Lymphocytes 24% | Monocytes 7.5% | Eosinophils 7.2% | Basophils 0.3% | 20-Mar-2018 | Not done | Cholesterol 5.4 mmol/L | Triglycerides 0.72 mmol/L | HDL Cholesterol 1.56 mmol/L | Calculated LDL Cholesterol 3.52 mmol/L | Risk Ratio LDL/HDL 2.5 | 20-Mar-2018 | Current smoker 10-12 cigs per day for over 25 years | |||
| EDP0000-AA900102937021718DD | Psoriasis | K2 EDTA Plasma | 1.00 | 10.00 | $75.00 | 37 Y | Male | Non-Hispanic | <-70C | 17-Feb-18 | Clinical Diagnosis | Psoriatric Arthritis | CT | MRI | Ultrasound | Xray Results | MRI - Bilateral Sacroileitis | Ultrasound - No significant data of disease | X-ray - Normal | 6-Feb-2018 | Current Disease Status | Flare | $75.00 | Unknown | Sandimmune - Neoral 200 mg/day + Ketoprofen 100 mg/day | Psoriasis | Moderate clinical activity of disease. Slight and moderate soreness in the feet and hands. 7-Feb-18 | L40.5 | Glucose 4.3 mmol/L | BUN 6.5 mmol/L | Creatinine 67 mmol/L | Sodium 145.2 mmol/L | Potassium 3.9 mmol/L | Calcium 1.24 mmol/L | Total Protein 73 g/L | SGOT (AST) 31 IU/L | SGPT (ALT) 27 IU/L | 7-Feb-2018 | WBC 6.2 x 10^9/L | RBC 4.9 x 10^12/L | Hemoglobin 141 g/L | Hematocrit 39% | MCV 80.5 fL | MCH 28.6 pg | MCHC 355 g/L | Neutrophils 46% | Lymphocytes 41% | Monocytes 11% | Eosinophils 1% | Basophils 1% | 7-Feb-2018 | CRP 17 mg/L | RF - Negative | 7-Feb-2018 | Cholesterol 5.1 mmol/L | 7-Feb-2018 | Diet; Current smoker 15-20 cigs per day for 20 years |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.